To demonstrate the use case, and commercial viability Unido Enterprise Platform(EP ),), it is useful to compare an established digital asset manager platform that has DeFi options. Enzyme (MLN) has been selected for competitor comparison and analysis, given it launched in July 2016 and provides similar services and features as EP, albeit delivered in very different formats.

Enzyme comes in two parts. It includes a front-end website for asset management, and an Ethereum-native protocol to deploy custom liquidity pool. This allows investors to use their digital assets (limited only to Ethereum-based tokens), in yield-returning activities without the need of investment managers or other fund management companies.

Given that all on-chain assets are managed by one client’s private key, this product is only for those who are willing to take full responsibility for their private keys. Due to the lack of corporate governance processes for security and operation of transaction sign-off, there is no multiparty signoff.

In comparison, EP’s product offers an integrated custodial function that is cross-chain interoperable and has blockchain-level multi-party sign-off for private keys operation. This makes it suitable for all investor classes including the asset manager and underserved enterprise investor segments. EP provides a Defi dashboard that aggregates different 3rd-party yield farming and staking options over multiple digital assets across multiple blockchains. This is presented as an investment “marketplace”. EP will offer access to tokenized real assets such as precious metals, which expands the investment options beyond those offered by blockchain-native utility tokens.

Despite Enzyme’s limitations in regards to the addressable market, due to a lack of key management options enabling sophisticated investors use their platform to access it, they have proven that: 1. To get a return on their digital assets, investors demand simple to use investment platforms. These services are available for a fee.

Enzyme has been extremely successful in attracting retail investors to their platform and have over $90 million in assets under management. In recognition of this AUM and future growth potential, the market has ascribed a market capitalisation of over $126mm to $MLN (the protocol governance token), based on a current token price of $69. 41 (fully diluted value, as of 27/07/2021).

In comparison, EP core technology is already built and the Defi dashboard will launch in 3Q2021 and is equipped with functionality to address a much wider client base. The $UDO utility token, which is used for governance and payment of services, has a market capitalization of $7. 36mm based on token price of $0. 08 (as of 27/07/2021).

The Unido leadership team views Enzyme to be an excellent example of the commercial appeal of cryptocurrency’s asset management dashboard space. $MLN trades at a 17x premium to $UDO (as of 27/07/2021), which would appear to be the result of

Enzyme has been on the market for many years, unlike EP.


Unido’s leadership team is excited about $MLNs market appeal. The EP product can compete directly against Enzyme for retail investors, but can also win enterprise and asset managers business, which can significantly increase AUM potential.

About Unido

Unido offers a suite of crypto custody solutions for enterprise and institutions, based on a state of the art fragmented private key signing engine, allowing distributed transaction signing at the blockchain level and providing corporate governance framework over crypto ownership.

This level of corporate governance and security technology is required by sophisticated organizations in order to confidently make the leap into cryptocurrency. Enhanced with a Defi investment dashboard, earning a yield from digital assets can be done quickly.

This is a sponsored post. Learn how to reach our audience here. Read disclaimer below.

Image Credits: Shutterstock, Pixabay, Wiki Commons

Disclaimer: This article is for informational purposes only. This article is not intended to be a solicitation or offer to buy or sell any products or services. Bitcoin.com does not provide investment, tax, legal, or accounting advice. The author and the company are not responsible for any loss or damage resulting from or related to the use or reliance of any content, goods, or services in this article.

Read More